The research comes two weeks after the Food and Drug Administration authorized pharmacists to prescribe Pfizer’s Covid-19 oral antiviral treatment Paxlovid in certain cases.
Covid Patients Should Take An Antiviral Even If They Don’t Have Severe Symptoms, Study Finds
